Results and discussion
The cDNAs encoding PLD1a and PLD1b were isolated from an HL60 cell cDNA library and cloned into the pCMV-neo-HA (provided by Onyx Pharmaceuticals) and pEGFP-C1 (Clontech) vectors. The PLD sequences were identical to those reported previously [6] except for a three amino acid insertion (EAV, in the single-letter amino-acid code) at position 1026. Expression of hemagglutinin (HA)-tagged and GFP-tagged PLD1b in COS-1 cells generated an ADP ribsolylation factor (ARF)-sensitive, phosphatidylinositol 4,5-bisphosphate (PIP 2 )-dependent PLD activity (Figure 1a ), which was stimulated by the inclusion of the Rho GTPase family member Rac (data not shown). Expression plasmids containing PLD1a generated similar PLD activities (data not shown).
To confirm that the tagged versions of PLD behaved identically in terms of intracellular localisation, COS-1 cells were co-transfected with both HA-PLD1b and GFP-PLD1b. Considerable overlap of the fusion proteins was observed ( Figure 1b) ; distribution of tagged PLD1b was usually punctate but, occasionally, a more diffuse distribution including some perinuclear staining was seen. Essentially no overlap of GFP-PLD1b expression was detected with an antibody (HFD9; [7] ) directed against a cis Golgi protein (Figure 1c ).
PLD1b expression has been detected in RBL-2H3 cells by northern blot hybridisation analysis (P.J. Parker, personal communication) and it is likely that this isoform is responsible for some of the IgE-receptor-stimulated activity [8] . In transfected RBL-2H3 cells, both GFP-PLD1b and HA-PLD1b displayed a punctate distribution with no plasma membrane or nuclear localisation. From published studies, a possible location for PLD would be the Golgi [2] . However, neither TGN 38 (Figure 2a) , a marker for an integral membrane protein predominately found in the trans-Golgi network, nor mannosidase II (Figure 2b) , which is expressed in the medial compartment of the Golgi stack, colocalised with GFP-PLD1b. HA-PLD also did not colocalise with TGN 38 in RBL-2H3 cells ( Figure  2c ). The Golgi markers displayed peri-nuclear staining identical to that in non-transfected cells, demonstrating that transfection had not disrupted Golgi structure.
There is evidence of a role for PLD in regulated exocytosis [9] . Therefore, PLD localisation was determined in comparison with secretory granule and lysosomal markers ( Figure 3 ). GFP-PLD1b fluorescence (Figure 3a ) and staining for 5-hydroxytryptamine (5HT; Figure 3b ), a marker of secretory granules, clearly overlapped (Figure 3c) . Similarly, GFP-PLD1b fluorescence (Figure 3d ) and staining for Lgp120 (Figure 3e ), a glycoprotein found in lysosomes, demonstrated considerable colocalisation (Figure 3f ). The Lys860→Glu (K860E) mutation of PLD1b was also generated and found to be catalytically inactive when expressed in COS-1 cells (data not shown). GFP-PLD1b-K860E also colocalised with 5HT (Figure 4e ), demonstrating that association was not a consequence of the elevated PLD activity induced by the GFP-tagging of PLD1b. Figure 4b shows a cell in which only a proportion of the secretory vesicles had translocated to the plasma membrane following a 3 minute stimulation. Not all of the GFP-PLD1b translocated to the plasma membrane, indeed in some cells considerable punctate GFP-PLD1b fluorescence remained observable after 40 minutes, the longest time point examined. To determine if the phosphatidic acid derived from stimulated PLD activity was required for translocation, its formation was inhibited by incubating cells with 0.3% butan-1-ol before IgE receptor ligation. No difference was observed in the stimulated relocation of GFP-PLD1 between the control and alcohol-treated cells (Figure 4d ). An identical pattern of staining was detected with GFP-PLD1a (data not shown). only inhibited degranulation by 30%. The dose dependency of stimulated phosphatidylbutanol formation in these cells correlated with the ability of the alcohol to block secretion, both being maximal at 0.1% butan-1-ol (data not shown and Figure 4f ). No phosphatidylbutan-2-ol was formed, suggesting that the inhibitory effects of butan-2-ol were non-specific. In contrast to receptor crosslinking, PMA did not stimulate the release of hexosaminidase (data not shown). Thus, whilst PLD activation is necessary for secretion, its plasma membrane recruitment and stimulation by protein kinase C (PKC) represent only two components of a complete secretory response. There are multiple steps in the exocytotic pathway and PMA clearly does not activate them all. For instance, an increase in intracellular Ca 2+ concentration is not generated by PMA and thus Ca 2+ -dependent proteins involved in secretion will not be activated.
The results presented in this paper clearly demonstrate that, in the RBL-2H3 cell line, PLD1 is present on the secretory granules and lysosomes and not, as might have been expected from published studies, on the Golgi [4,10,11], ER [1] or nucleus [2, 5] . Secretory granules of cells in the haematopoietic lineage are 'secretory lysosomes' [12] , which contain lysosomal hydrolases and secretory proteins.
Substantial biochemical evidence exists to support a role for a PLD activity in the formation of coated vesicles during membrane transport through the secretory pathway [12] . Subcellular localisation studies have not, however, unequivocally demonstrated PLD in the corresponding organelles. The overexpression of an HA-epitope-tagged PLD1 in serum-starved REF-52 fibroblasts resulted in a staining pattern consistent with the Golgi, ER and late endosomes, but the lack of colocalisation data using markers to these or other subcellular compartments left the exact location of PLD1 undetermined [4] . Other localisation studies have been based on subcellular fractionation and subsequent assay of PLD activity, which does not distinguish between isoforms. These were largely unable to detect any PLD activity in fractions corresponding to granules and lysosomes.
Recently, a PLD activity was detected associated with neutrophil vesicles that can, following stimulation, be found at the plasma membrane [13] ; our results suggest that this activity may be composed of PLD1b and/or PLD1a. We found no evidence for localisation of PLD1a or PLD1b to the Golgi or ER, and therefore must question the role of these particular isoforms in ER to Golgi transport events. Nevertheless, the biochemical evidence for a PLD activity in this process is strong [1] . PLD2, because of its constitutively active state, is a potential candidate for this function, although recent data suggest that it is localised to the plasma membrane [4] . Thus, the PLD isoforms involved in other vesicle transport steps remain to be identified. It is possible that the localisation of PLD isoforms is cell specific or that additional PLD isoforms remain to be identified.
The data presented in this paper support a model whereby PLD1, present on secretory granules and lysosomes, is recruited to the plasma membrane in response to antigen stimulation. During this process, PLD is activated and generates phosphatidic acid, which fulfils an essential role in the secretion of the contents of the vesicles with which PLD1 colocalises. We do not rule out the possibility that the conversion of phosphatidic acid to diacylglycerol is necessary for secretion as reported in yeast [14] . There is, however, increasing evidence to indicate that phosphatidic acid is the signal generated by PLD [15] .
Materials and methods

Culture and transfection of cells
COS-1 and RBL-2H3 cells were transfected by electroporation and allowed to adhere to coverslips or dishes overnight in fresh medium. Anti-DNP IgE (1 µg/ml) was included for at least 1 h prior to PBS washing and stimulation with 1 µg/ml KLH-DNP (Calbiochem). Identical data were obtained when cells were examined 48 h post-transfection. For secretory experiments, cells were incubated overnight with 1 µCi/ml [ 3 H]5HT.
Confocal microscopy
Golgi membranes were stained with monoclonal antibodies against TGN 38, mannosidase II (both kindly provided by G. Banting) or with HFD9 monoclonal antibody (kindly provided by V.N. Subramaniam) [7] . Endosomes were stained with a monoclonal antibody to the transferrin receptor (kindly provided by C. Hopkins). Lysosomes were visualised with a monoclonal antibody against the lysosomal glycoprotein Lgp120 (kindly provided by I. Mellman) and secretory granules visualised using a monoclonal antibody to 5HT (Biogenesis).
Analysis of regulated secretion
Secretion from RBL-2H3 cells was quantified by determining the release of hexosaminidase enzymatically using p-nitrophenyl-N-acetyl-Dglucosamine as a substrate and the release of [ 3 H]5HT, measured by scintillation counting.
Determination of PLD activity
Transfected COS-1 cells were lysed and PLD activity determined using a [ 3 H]phosphatidylcholine-containing substrate micelle with [ 3 H]choline generation determined as described [16] .
